Breaking News Instant updates and real-time market news.

MAR

Marriott

$114.35

-7.43 (-6.10%)

, EFX

Equifax

$102.18

-0.53 (-0.52%)

13:37
11/30/18
11/30
13:37
11/30/18
13:37

Comparison of Marriott breach to Equifax a 'much too dire' view, says JPMorgan

JPMorgan analyst Joseph Greff believes it is "way too early" to quantify the financial impact to Marriott (MAR) of the company's data breach, which he notes is large in terms of number of guests and "deep" in terms of the types of data - such as passport, credit card and address information - that may have been exposed. Marriot shares appear to be to be pricing in a "sizable permanent impact," given that the roughly 6% pullback implies $130M-$135M in lost net income using its current 2019 P/E multiple, Greff tells investors. His general view is that any damage done to the brand longer-term will likely be minimal, if there is any at all, adding that "consumers are growing somewhat numb to these events." In his conversations today, the "kneejerk comparison" has been to Equifax's (EFX) breach last year, but that comparison "is (much) too dire," Greff believes. He maintains an Overweight rating on Marriott shares.

MAR

Marriott

$114.35

-7.43 (-6.10%)

EFX

Equifax

$102.18

-0.53 (-0.52%)

  • 30

    Nov

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

MAR Marriott
$114.35

-7.43 (-6.10%)

11/30/18
JPMS
11/30/18
NO CHANGE
JPMS
Marriott data breach impact too early to quantify, says JPMorgan
11/30/18
JEFF
11/30/18
NO CHANGE
Target $124
JEFF
Hold
Marriott financial impact from breach likely marginal, says Jefferies
After Marriott disclosed it is investigating a data security incident involving a Starwood guest reservation database that contains information on up to approximately 500M guests, including approximately 327M of whom may have had sensitive information accessed, Jefferies analyst David Katz said he believes the announcement will pressure shares in the near-term, but he does not expect a meaningful financial impact either in the near-term or long term-term. While he thinks any revisions to estimates will be marginal, Katz does think "it is prudent to contemplate" the possibility for near-term, headline-driven apprehension in new bookings, the possible medium- to longer-term impact of customers leaving to competitors and the near-term expenses and any potential charges or settlements. He keeps a Hold rating on Marriott shares, citing valuation, with a $124 price target.
11/27/18
11/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from In-Line at Imperial Capital with analyst David Miller saying while fiscal 2019 should be a "transitional year," fiscal 2020 brings an "abundance of catalysts." 2. Citizens Financial (CFG) upgraded to Outperform from Neutral at Macquarie. 3. Parsley Energy (PE) upgraded to Buy from Neutral at Goldman Sachs with analyst John Nelson saying greater appreciation of the the company's free cash flow inflection in the second half of 2019 should drive improved investor sentiment. 4. Taubman Centers (TCO) was upgraded to Sector Perform from Underperform at Scotiabank and to Equal Weight from Underweight at Morgan Stanley. 5. Marriott (MAR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Stephen Grambling saying the stock has been penalized recently amid Starwood integration issues, but these will prove temporary and position Marriott better in the future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/27/18
GSCO
11/27/18
DOWNGRADE
Target $70
GSCO
Buy
Wyndham Hotels & Resorts downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Stephen Grambling removed Wyndham Hotels & Resorts (WYN) from his firm's America's Conviction List while keeping a Buy rating on the shares. The analyst lowered his price target for the stock to $70 from $76. Grambling reduced his estimates for Wyndham to reflect incremental caution around timeshare amid softening housing data and rising rates. However, he continues to believe upside from the La Quinta acquisition, accelerating unit growth, and fee rates should all drive upside to consensus estimates and a "re-rating" versus peers. Nonetheless, Grambling sees a more attractive risk/reward in shares of Marriott (MAR).
EFX Equifax
$102.18

-0.53 (-0.52%)

11/30/18
LEHM
11/30/18
UPGRADE
Target $225
LEHM
Overweight
Barclays upgrades Fair Isaac to Overweight following recent pullback
Barclays analyst Manav Patnaik upgraded Fair Isaac (FICO) to Overweight from Equal Weight and raised his price target for the shares to $225 from $200. The analyst says his constructive view on the stock comes on the back of the recent pullback as well as his appreciation of the company's evolution as a Software name. Patnaik prefers shares of Fair Isaac and TransUnion (TRU) over Equifax (EFX) and Dun & Bradstreet (DNB).
10/26/18
WELS
10/26/18
NO CHANGE
Target $137
WELS
Outperform
Equifax selloff creates attractive risk/reward, says Wells Fargo
Wells Fargo analyst William Warmington believes the post-earnings selloff yesterday in shares of Equifax creates an attractive risk/reward profile. The analyst lowered his price target for the stock to $137 from $145 and keeps an Outperform rating on the name. Equifax's issues are related to the macro environment and deal delays in Financial Marketing Solutions, not competitive issues, Warmington tells investors in a post-earnings research note titled "Deja Vu All Over Again. . ." The stock is at a level not seen since September 2017 immediately following the data breach, but offers a more attractive risk/reward for long-term investors than last September, the analyst claims. He believes concerns are market share loss are overblown and that Equifax's IT transformation is a "major plus."
10/23/18
BOFA
10/23/18
INITIATION
Target $123
BOFA
Underperform
Equifax reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Gary Bisbee reinstated coverage on Equifax with an Underperform and $123 price target telling investors the company will eventually work through data breach issues and a rebound in shares will take time. Bisbee also said costs to remediate the system are building and expects the company will be among the slowest profit growers in the group.
06/25/18
WBLR
06/25/18
NO CHANGE
WBLR
Outperform
Equifax 'Most Improved' at Annual Growth conference, says William Blair
Following the firm's 38th Annual Growth Stock Conference, William Blair analyst Timothy McHugh added Equifax to his "Weekly Top Five" list, telling investors that the stock could be awarded "Most Improved" from the conference as investors walked away "with hope and even confidence" that things are turning around. According to McHugh, Equifax management stated that they are "out of the penalty box" with a majority of their customers, adding that new CEO Mark Begor is being "very aggressive" with personal outreach to these clients and believes the company is willing to be aggressive with pricing if need be. Further, McHugh, has an Outperform rating on Equifax shares, believes it is looking less likely that the company will shut down its U.S. direct-to-consumer business abruptly.

TODAY'S FREE FLY STORIES

11:20
12/12/19
12/12
11:20
12/12/19
11:20
General news
Treasury announced a $78 B in 3- and 6-month bill auctions for Monday »

Treasury announced a $78…

SSNLF

Samsung

$0.00

(0.00%)

11:19
12/12/19
12/12
11:19
12/12/19
11:19
Periodicals
Exec says Samsung has sold 1M Galaxy Fold smartphones, TechCrunch reports »

Young Sohn, the president…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/12/19
12/12
11:17
12/12/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/12/19
12/12
11:16
12/12/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
12/12/19
12/12
11:15
12/12/19
11:15
General news
Today's U.S. reports »

Today's U.S. reports…

11:15
12/12/19
12/12
11:15
12/12/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
12/12/19
12/12
11:15
12/12/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
12/12/19
12/12
11:15
12/12/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
12/12/19
12/12
11:15
12/12/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:14
12/12/19
12/12
11:14
12/12/19
11:14
Conference/Events
JPMorgan aerospace & defense analyst to hold an analyst/industry conference call »

Aerospace & Defense…

11:09
12/12/19
12/12
11:09
12/12/19
11:09
General news
5-Yr TIPS Announcement CUSIP Number data reported »

5-Yr TIPS Announcement…

11:09
12/12/19
12/12
11:09
12/12/19
11:09
General news
5-Yr TIPS Announcement Offering Amount data reported »

5-Yr TIPS Announcement…

EH

Ehang

$0.00

(0.00%)

11:09
12/12/19
12/12
11:09
12/12/19
11:09
Syndicate
Breaking Syndicate news story on Ehang »

Ehang opens at $12.55,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SHAK

Shake Shack

$59.20

0.29 (0.49%)

11:05
12/12/19
12/12
11:05
12/12/19
11:05
Options
Shake Shack call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

MCK

McKesson

$144.02

0.62 (0.43%)

11:02
12/12/19
12/12
11:02
12/12/19
11:02
Hot Stocks
McKesson selected to continue as prime pharmaceutical supplier for VA »

McKesson Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$146.49

2.42 (1.68%)

10:58
12/12/19
12/12
10:58
12/12/19
10:58
Downgrade
Caterpillar rating change  »

Caterpillar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BILL

Bill.com

$0.00

(0.00%)

10:58
12/12/19
12/12
10:58
12/12/19
10:58
Syndicate
Breaking Syndicate news story on Bill.com »

Bill.com indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EH

Ehang

$0.00

(0.00%)

10:58
12/12/19
12/12
10:58
12/12/19
10:58
Syndicate
Breaking Syndicate news story on Ehang »

Ehang indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BBU

Brookfield Business Partners

$40.99

(0.00%)

, GNW

Genworth

$4.60

0.135 (3.03%)

10:55
12/12/19
12/12
10:55
12/12/19
10:55
Hot Stocks
Genworth completes Genworth MI Canada stake sale to Brookfield Business Partners »

Genworth Financial (GNW)…

BBU

Brookfield Business Partners

$40.99

(0.00%)

GNW

Genworth

$4.60

0.135 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

10:55
12/12/19
12/12
10:55
12/12/19
10:55
General news
Treasury 30-year auction outlook: the $16 B reopening rounds out this week's auctions »

Treasury 30-year auction…

TSLA

Tesla

$359.21

6.81 (1.93%)

10:51
12/12/19
12/12
10:51
12/12/19
10:51
Periodicals
Tesla loses third general counsel this year, Bloomberg Law says »

Jonathan Chang, who was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

GE

General Electric

$11.42

0.44 (4.01%)

10:46
12/12/19
12/12
10:46
12/12/19
10:46
On The Fly
GE jumps as UBS predicts positive inflection point in 2020 »

Shares of General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BILL

Bill.com

$0.00

(0.00%)

10:45
12/12/19
12/12
10:45
12/12/19
10:45
Syndicate
Breaking Syndicate news story on Bill.com »

Bill.com indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ABBV

AbbVie

$88.15

1.46 (1.68%)

10:45
12/12/19
12/12
10:45
12/12/19
10:45
Options
AbbVie call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/12/19
12/12
10:45
12/12/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.